Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Liontrust reports slightly higher net outflows

(Sharecast News) - Liontrust Asset Management reported net outflows of £1.3bn for the three months ended 31 March in an update on Tuesday, slightly above the £1.2bn recorded in the same period last year, as challenging market conditions continued to weigh on investor sentiment. The London-listed firm said assets under management and advice fell 8.1% over the quarter to £22.6bn.

By 10 April, total assets had declined further to £21.6bn, reflecting continued market volatility and investor redemptions.

Despite the outflows, the company said it was progressing with its strategic initiatives, including expanding its investment capability and international distribution.

Liontrust also noted it was completing the implementation of its enhanced operating model, aimed at improving efficiency and supporting long-term growth.

"It feels that over the past few years, the only certainty has been uncertainty," said chief executive officer John Ions.

"The current day-to-day unpredictability and fluctuations in markets reinforces our belief in active management and the long-term power of robust and repeatable investment processes.

"Our focus remains on what is within our control; we continue to develop the business and are confident we have been making the right changes to ensure it is in the best possible shape for the future."

At 0906 BST, shares in Liontrust Asset Management were up 0.51% at 336.72p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.